Global Diabetes Devices and Drugs Market Size, Status and Forecast 2024-2031

Report ID: 919998 | Published Date: Sep 2024 | No. of Page: 126 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Diabetes Devices
        1.2.3 Diabetes Drugs
    1.3 Market by Application
        1.3.1 Global Diabetes Devices and Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostic/Clinics
        1.3.3 ICUs
        1.3.4 Home Healthcare
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Diabetes Devices and Drugs Market Perspective (2016-2027)
    2.2 Diabetes Devices and Drugs Growth Trends by Regions
        2.2.1 Diabetes Devices and Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Diabetes Devices and Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Diabetes Devices and Drugs Industry Dynamic
        2.3.1 Diabetes Devices and Drugs Market Trends
        2.3.2 Diabetes Devices and Drugs Market Drivers
        2.3.3 Diabetes Devices and Drugs Market Challenges
        2.3.4 Diabetes Devices and Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Diabetes Devices and Drugs Players by Revenue
        3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2016-2021)
        3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
    3.4 Global Diabetes Devices and Drugs Market Concentration Ratio
        3.4.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2020
    3.5 Diabetes Devices and Drugs Key Players Head office and Area Served
    3.6 Key Players Diabetes Devices and Drugs Product Solution and Service
    3.7 Date of Enter into Diabetes Devices and Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Devices and Drugs Breakdown Data by Type
    4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2022-2027)

5 Diabetes Devices and Drugs Breakdown Data by Application
    5.1 Global Diabetes Devices and Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Diabetes Devices and Drugs Market Size (2016-2027)
    6.2 North America Diabetes Devices and Drugs Market Size by Type
        6.2.1 North America Diabetes Devices and Drugs Market Size by Type (2016-2021)
        6.2.2 North America Diabetes Devices and Drugs Market Size by Type (2022-2027)
        6.2.3 North America Diabetes Devices and Drugs Market Size by Type (2016-2027)
    6.3 North America Diabetes Devices and Drugs Market Size by Application
        6.3.1 North America Diabetes Devices and Drugs Market Size by Application (2016-2021)
        6.3.2 North America Diabetes Devices and Drugs Market Size by Application (2022-2027)
        6.3.3 North America Diabetes Devices and Drugs Market Size by Application (2016-2027)
    6.4 North America Diabetes Devices and Drugs Market Size by Country
        6.4.1 North America Diabetes Devices and Drugs Market Size by Country (2016-2021)
        6.4.2 North America Diabetes Devices and Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Diabetes Devices and Drugs Market Size (2016-2027)
    7.2 Europe Diabetes Devices and Drugs Market Size by Type
        7.2.1 Europe Diabetes Devices and Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Diabetes Devices and Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Diabetes Devices and Drugs Market Size by Type (2016-2027)
    7.3 Europe Diabetes Devices and Drugs Market Size by Application
        7.3.1 Europe Diabetes Devices and Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Diabetes Devices and Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Diabetes Devices and Drugs Market Size by Application (2016-2027)
    7.4 Europe Diabetes Devices and Drugs Market Size by Country
        7.4.1 Europe Diabetes Devices and Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Diabetes Devices and Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Diabetes Devices and Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type
        8.2.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Application
        8.3.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Diabetes Devices and Drugs Market Size by Region
        8.4.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Diabetes Devices and Drugs Market Size (2016-2027)
    9.2 Latin America Diabetes Devices and Drugs Market Size by Type
        9.2.1 Latin America Diabetes Devices and Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Diabetes Devices and Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Diabetes Devices and Drugs Market Size by Type (2016-2027)
    9.3 Latin America Diabetes Devices and Drugs Market Size by Application
        9.3.1 Latin America Diabetes Devices and Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Diabetes Devices and Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Diabetes Devices and Drugs Market Size by Application (2016-2027)
    9.4 Latin America Diabetes Devices and Drugs Market Size by Country
        9.4.1 Latin America Diabetes Devices and Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Diabetes Devices and Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Diabetes Devices and Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type
        10.2.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Application
        10.3.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Diabetes Devices and Drugs Market Size by Country
        10.4.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Medtronic
        11.1.1 Medtronic Company Details
        11.1.2 Medtronic Business Overview
        11.1.3 Medtronic Diabetes Devices and Drugs Introduction
        11.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.1.5 Medtronic Recent Development
    11.2 BD
        11.2.1 BD Company Details
        11.2.2 BD Business Overview
        11.2.3 BD Diabetes Devices and Drugs Introduction
        11.2.4 BD Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.2.5 BD Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
        11.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.4.5 Abbott Laboratories Recent Development
    11.5 Novo Nordisk
        11.5.1 Novo Nordisk Company Details
        11.5.2 Novo Nordisk Business Overview
        11.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
        11.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.5.5 Novo Nordisk Recent Development
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Details
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.6.5 Bristol-Myers Squibb Recent Development
    11.7 DexCom
        11.7.1 DexCom Company Details
        11.7.2 DexCom Business Overview
        11.7.3 DexCom Diabetes Devices and Drugs Introduction
        11.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.7.5 DexCom Recent Development
    11.8 Companion Medical
        11.8.1 Companion Medical Company Details
        11.8.2 Companion Medical Business Overview
        11.8.3 Companion Medical Diabetes Devices and Drugs Introduction
        11.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.8.5 Companion Medical Recent Development
    11.9 GlaxoSmithKline
        11.9.1 GlaxoSmithKline Company Details
        11.9.2 GlaxoSmithKline Business Overview
        11.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
        11.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.9.5 GlaxoSmithKline Recent Development
    11.10 Glenmark Pharmaceuticals
        11.10.1 Glenmark Pharmaceuticals Company Details
        11.10.2 Glenmark Pharmaceuticals Business Overview
        11.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
        11.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.10.5 Glenmark Pharmaceuticals Recent Development
    11.11 Novartis
        11.11.1 Novartis Company Details
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Diabetes Devices and Drugs Introduction
        11.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.11.5 Novartis Recent Development
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche Diabetes Devices and Drugs Introduction
        11.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.12.5 Roche Recent Development
    11.13 Sanofi
        11.13.1 Sanofi Company Details
        11.13.2 Sanofi Business Overview
        11.13.3 Sanofi Diabetes Devices and Drugs Introduction
        11.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.13.5 Sanofi Recent Development
    11.14 MSD
        11.14.1 MSD Company Details
        11.14.2 MSD Business Overview
        11.14.3 MSD Diabetes Devices and Drugs Introduction
        11.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.14.5 MSD Recent Development
    11.15 Astrazeneca
        11.15.1 Astrazeneca Company Details
        11.15.2 Astrazeneca Business Overview
        11.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
        11.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.15.5 Astrazeneca Recent Development
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Diabetes Devices and Drugs Introduction
        11.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.16.5 Takeda Recent Development
    11.17 North China Pharmaceutical Group Corporation
        11.17.1 North China Pharmaceutical Group Corporation Company Details
        11.17.2 North China Pharmaceutical Group Corporation Business Overview
        11.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
        11.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.17.5 North China Pharmaceutical Group Corporation Recent Development
    11.18 Huadong Medicine
        11.18.1 Huadong Medicine Company Details
        11.18.2 Huadong Medicine Business Overview
        11.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
        11.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.18.5 Huadong Medicine Recent Development
    11.18 Dongbao Pharmaceutical
        .1 Dongbao Pharmaceutical Company Details
        .2 Dongbao Pharmaceutical Business Overview
        .3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
        .4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021)
        .5 Dongbao Pharmaceutical Recent Development
    11.20 Hisun Pharmacy
        11.20.1 Hisun Pharmacy Company Details
        11.20.2 Hisun Pharmacy Business Overview
        11.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
        11.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.20.5 Hisun Pharmacy Recent Development
    11.21 KELUN
        11.21.1 KELUN Company Details
        11.21.2 KELUN Business Overview
        11.21.3 KELUN Diabetes Devices and Drugs Introduction
        11.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.21.5 KELUN Recent Development
    11.22 Ginwa
        11.22.1 Ginwa Company Details
        11.22.2 Ginwa Business Overview
        11.22.3 Ginwa Diabetes Devices and Drugs Introduction
        11.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.22.5 Ginwa Recent Development
    11.23 Tianan Pharmaceutical
        11.23.1 Tianan Pharmaceutical Company Details
        11.23.2 Tianan Pharmaceutical Business Overview
        11.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
        11.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021)
        11.23.5 Tianan Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Diabetes Devices and Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Diabetes Devices
    Table 3. Key Players of Diabetes Drugs
    Table 4. Global Diabetes Devices and Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Diabetes Devices and Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Diabetes Devices and Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Diabetes Devices and Drugs Market Share by Regions (2016-2021)
    Table 8. Global Diabetes Devices and Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Diabetes Devices and Drugs Market Share by Regions (2022-2027)
    Table 10. Diabetes Devices and Drugs Market Trends
    Table 11. Diabetes Devices and Drugs Market Drivers
    Table 12. Diabetes Devices and Drugs Market Challenges
    Table 13. Diabetes Devices and Drugs Market Restraints
    Table 14. Global Diabetes Devices and Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Diabetes Devices and Drugs Market Share by Players (2016-2021)
    Table 16. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2020)
    Table 17. Ranking of Global Top Diabetes Devices and Drugs Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Diabetes Devices and Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Diabetes Devices and Drugs Product Solution and Service
    Table 21. Date of Enter into Diabetes Devices and Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Diabetes Devices and Drugs Revenue Market Share by Type (2016-2021)
    Table 25. Global Diabetes Devices and Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Diabetes Devices and Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Diabetes Devices and Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Diabetes Devices and Drugs Revenue Market Share by Application (2016-2021)
    Table 29. Global Diabetes Devices and Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Diabetes Devices and Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Medtronic Company Details
    Table 62. Medtronic Business Overview
    Table 63. Medtronic Diabetes Devices and Drugs Product
    Table 64. Medtronic Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 65. Medtronic Recent Development
    Table 66. BD Company Details
    Table 67. BD Business Overview
    Table 68. BD Diabetes Devices and Drugs Product
    Table 69. BD Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 70. BD Recent Development
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Diabetes Devices and Drugs Product
    Table 74. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. Abbott Laboratories Company Details
    Table 77. Abbott Laboratories Business Overview
    Table 78. Abbott Laboratories Diabetes Devices and Drugs Product
    Table 79. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 80. Abbott Laboratories Recent Development
    Table 81. Novo Nordisk Company Details
    Table 82. Novo Nordisk Business Overview
    Table 83. Novo Nordisk Diabetes Devices and Drugs Product
    Table 84. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 85. Novo Nordisk Recent Development
    Table 86. Bristol-Myers Squibb Company Details
    Table 87. Bristol-Myers Squibb Business Overview
    Table 88. Bristol-Myers Squibb Diabetes Devices and Drugs Product
    Table 89. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 90. Bristol-Myers Squibb Recent Development
    Table 91. DexCom Company Details
    Table 92. DexCom Business Overview
    Table 93. DexCom Diabetes Devices and Drugs Product
    Table 94. DexCom Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 95. DexCom Recent Development
    Table 96. Companion Medical Company Details
    Table 97. Companion Medical Business Overview
    Table 98. Companion Medical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 99. Companion Medical Recent Development
    Table 100. GlaxoSmithKline Company Details
    Table 101. GlaxoSmithKline Business Overview
    Table 102. GlaxoSmithKline Diabetes Devices and Drugs Product
    Table 103. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 104. GlaxoSmithKline Recent Development
    Table 105. Glenmark Pharmaceuticals Company Details
    Table 106. Glenmark Pharmaceuticals Business Overview
    Table 107. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product
    Table 108. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 109. Glenmark Pharmaceuticals Recent Development
    Table 110. Novartis Company Details
    Table 111. Novartis Business Overview
    Table 112. Novartis Diabetes Devices and Drugs Product
    Table 113. Novartis Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 114. Novartis Recent Development
    Table 115. Roche Company Details
    Table 116. Roche Business Overview
    Table 117. Roche Diabetes Devices and Drugs Product
    Table 118. Roche Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 119. Roche Recent Development
    Table 120. Sanofi Company Details
    Table 121. Sanofi Business Overview
    Table 122. Sanofi Diabetes Devices and Drugs Product
    Table 123. Sanofi Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 124. Sanofi Recent Development
    Table 125. MSD Company Details
    Table 126. MSD Business Overview
    Table 127. MSD Diabetes Devices and Drugs Product
    Table 128. MSD Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 129. MSD Recent Development
    Table 130. Astrazeneca Company Details
    Table 131. Astrazeneca Business Overview
    Table 132. Astrazeneca Diabetes Devices and Drugs Product
    Table 133. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 134. Astrazeneca Recent Development
    Table 135. Takeda Company Details
    Table 136. Takeda Business Overview
    Table 137. Takeda Diabetes Devices and Drugs Product
    Table 138. Takeda Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 139. Takeda Recent Development
    Table 140. North China Pharmaceutical Group Corporation Company Details
    Table 141. North China Pharmaceutical Group Corporation Business Overview
    Table 142. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product
    Table 143. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 144. North China Pharmaceutical Group Corporation Recent Development
    Table 145. Huadong Medicine Company Details
    Table 146. Huadong Medicine Business Overview
    Table 147. Huadong Medicine Diabetes Devices and Drugs Product
    Table 148. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 149. Huadong Medicine Recent Development
    Table 150. Dongbao Pharmaceutical Company Details
    Table 151. Dongbao Pharmaceutical Business Overview
    Table 152. Dongbao Pharmaceutical Diabetes Devices and Drugs Product
    Table 153. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 154. Dongbao Pharmaceutical Recent Development
    Table 155. Hisun Pharmacy Company Details
    Table 156. Hisun Pharmacy Business Overview
    Table 157. Hisun Pharmacy Diabetes Devices and Drugs Product
    Table 158. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 159. Hisun Pharmacy Recent Development
    Table 160. KELUN Company Details
    Table 161. KELUN Business Overview
    Table 162. KELUN Diabetes Devices and Drugs Product
    Table 163. KELUN Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 164. KELUN Recent Development
    Table 165. Ginwa Company Details
    Table 166. Ginwa Business Overview
    Table 167. Ginwa Diabetes Devices and Drugs Product
    Table 168. Ginwa Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 169. Ginwa Recent Development
    Table 170. Tianan Pharmaceutical Company Details
    Table 171. Tianan Pharmaceutical Business Overview
    Table 172. Tianan Pharmaceutical Diabetes Devices and Drugs Product
    Table 173. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
    Table 174. Tianan Pharmaceutical Recent Development
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetes Devices and Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Diabetes Devices Features
    Figure 3. Diabetes Drugs Features
    Figure 4. Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2027
    Figure 5. Diagnostic/Clinics Case Studies
    Figure 6. ICUs Case Studies
    Figure 7. Home Healthcare Case Studies
    Figure 8. Diabetes Devices and Drugs Report Years Considered
    Figure 9. Global Diabetes Devices and Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Diabetes Devices and Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Diabetes Devices and Drugs Market Share by Regions: 2020 VS 2027
    Figure 12. Global Diabetes Devices and Drugs Market Share by Regions (2022-2027)
    Figure 13. Global Diabetes Devices and Drugs Market Share by Players in 2020
    Figure 14. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2020
    Figure 16. Global Diabetes Devices and Drugs Revenue Market Share by Type (2016-2021)
    Figure 17. Global Diabetes Devices and Drugs Revenue Market Share by Type (2022-2027)
    Figure 18. North America Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Diabetes Devices and Drugs Market Share by Type (2016-2027)
    Figure 20. North America Diabetes Devices and Drugs Market Share by Application (2016-2027)
    Figure 21. North America Diabetes Devices and Drugs Market Share by Country (2016-2027)
    Figure 22. United States Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Diabetes Devices and Drugs Market Share by Type (2016-2027)
    Figure 26. Europe Diabetes Devices and Drugs Market Share by Application (2016-2027)
    Figure 27. Europe Diabetes Devices and Drugs Market Share by Country (2016-2027)
    Figure 28. Germany Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Diabetes Devices and Drugs Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Diabetes Devices and Drugs Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Diabetes Devices and Drugs Market Share by Region (2016-2027)
    Figure 38. China Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Diabetes Devices and Drugs Market Share by Type (2016-2027)
    Figure 46. Latin America Diabetes Devices and Drugs Market Share by Application (2016-2027)
    Figure 47. Latin America Diabetes Devices and Drugs Market Share by Country (2016-2027)
    Figure 48. Mexico Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Diabetes Devices and Drugs Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Diabetes Devices and Drugs Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Diabetes Devices and Drugs Market Share by Country (2016-2027)
    Figure 54. Turkey Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 58. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 61. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 63. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 64. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 66. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 67. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 68. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 70. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 71. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 72. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 73. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 74. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 75. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 76. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 77. KELUN Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 78. Ginwa Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 79. Tianan Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Medtronic
BD
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Bristol-Myers Squibb
DexCom
Companion Medical
GlaxoSmithKline
Glenmark Pharmaceuticals
Novartis
Roche
Sanofi
MSD
Astrazeneca
Takeda
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Frequently Asked Questions
Diabetes Devices and Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetes Devices and Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetes Devices and Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports